2. Fibromyalgia syndrome

Medical Journal of Australia

Volumn 165, Issue 7, 1996, Pages 387-391

  Littlejohn, Geoffrey O ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CYCLOBENZAPRINE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR;

ALLODYNIA; BLADDER DISEASE; CLINICAL TRIAL; DEPRESSION; DERMOGRAPHISM; EXERCISE; FATIGUE; FIBROMYALGIA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEDICAL EXAMINATION; META ANALYSIS; MUSCLE STIFFNESS; NOCICEPTION; NONREM SLEEP; PAIN; PATIENT COUNSELING; SHORT SURVEY; SLEEP DISORDER; SPINAL CORD DORSAL HORN; ARTICLE; PATIENT REFERRAL; PHYSICAL EXAMINATION;

FIBROMYALGIA; HUMANS; PHYSICAL EXAMINATION; REFERRAL AND CONSULTATION;

EID: 0030573943     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb125026.x     Document Type: Short Survey

References (19)

1. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia, BMJ 1994; 309: 696-699
2. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyaglia in the general population. Arthritis Rheum 1995; 38: 19-28.
3. Yunus MB. Fibromyalgia syndrome: clinical features and spectrum. J Musculoske Pain 1994; 2: 5-18.
4. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1181-1184.
5. Simms RW. Muscle studies in fibromyalgia syndrome. J Musculoske Pain 1994; 2: 117-123.
6. Ursin H Endresen IM, Haland E, Mjellem N. Sensitization: a neurobiological theory for muscle pain. In: Vaeroy H, Merskey H, editors. Progress in fibromyalgia and myofascial pain. Amsterdam: Elsevier, 1993: 413-428.
7. Russell IJ. Biochemical abnormalities in fibromyalgia syndrome. J Musculoske Pain 1993; 2: 101-116.
8. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583-1592.
9. Bennett RM, Clark SR, Campbell SM, Burckardt CS. Somatomedin C levels in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992: 35: 1113-1116.
10. Lue FA. Sleep and fibromyalgia. J Musculoske Pain 1993; 3: 89-100.
11. Goldenberg DL. Psychiatric illness and fibromyalgia. J Musculoske Pain 1993; 3: 41-49.
12. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926-938.
13. Woolf CJ. A new strategy for the treatment of inflammatory pain: prevention or elimination of central sensitization Drugs 1994; 47 Suppl 5: 1-9.
14. Littlejohn GO, Granges G. The relationship between vertebral dysfunction and the clinical features of fibromyalgia syndrome. J Orthopaed Rheum 1995; 8: 97-105.
15. Smythe HA. The C6-7 syndrome - clinical features and treatment response. J Rheumatol 1994; 21: 1520-1526
16. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multi Center Criteria Committee. Arthritis Rheum 1990; 33: 160-172.
17. Granges G, Zilko P, Littlejohn GO. Fibromyalgia syndrome: assessment of severity of the condition two years after diagnosis. J Rheumatol 1994; 21: 523-529.
18. Bennett RM. Exercise and exercise testing in fibromyalgia patients: lessons learned and suggestions for future studies. J Musculoske Pain 1994; 2: 143-152.
19. Wolfe F, Aartlot T, Bruusgaard D. et al. Fibromyalgia and disability: report of the Moss International Working Group on Medicolegal Aspects of Chronic Widespread Musculoskeletal Pain Complaints and Fibromyalgia. Scand J Rheumatol 1995; 24: 112-118.